CA2348693A1 - Natural formulation for the treatment and prevention of depression, containing st john's wort and derivatives of dihydro- and tetrahydrofolic acid - Google Patents

Natural formulation for the treatment and prevention of depression, containing st john's wort and derivatives of dihydro- and tetrahydrofolic acid Download PDF

Info

Publication number
CA2348693A1
CA2348693A1 CA002348693A CA2348693A CA2348693A1 CA 2348693 A1 CA2348693 A1 CA 2348693A1 CA 002348693 A CA002348693 A CA 002348693A CA 2348693 A CA2348693 A CA 2348693A CA 2348693 A1 CA2348693 A1 CA 2348693A1
Authority
CA
Canada
Prior art keywords
wort
dihydro
john
depression
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002348693A
Other languages
French (fr)
Other versions
CA2348693C (en
Inventor
Herwig Buchholz
Angela Dudda
Jerzy Meduski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2348693A1 publication Critical patent/CA2348693A1/en
Application granted granted Critical
Publication of CA2348693C publication Critical patent/CA2348693C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/38Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to novel compositions containing a combination of the plant St. John's Wort (Hypericum perforatum L.), its extracts of active ingredients and derivatives of dihydro- and tetrahydrofolic acid. This natural formulation is useful for the treatment and prevention of depression with a better effect than the ingredient compounds alone.
CA002348693A 1998-10-19 1999-10-08 Natural formulation for the treatment and prevention of depression, containing st john's wort and derivatives of dihydro- and tetrahydrofolic acid Expired - Fee Related CA2348693C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10471098P 1998-10-19 1998-10-19
US60/104,710 1998-10-19
PCT/EP1999/007556 WO2000023089A1 (en) 1998-10-19 1999-10-08 Natural formulation for the treatment and prevention of depression, containing st john's wort and derivatives of dihydro- and tetrahydrofolic acid

Publications (2)

Publication Number Publication Date
CA2348693A1 true CA2348693A1 (en) 2000-04-27
CA2348693C CA2348693C (en) 2008-07-15

Family

ID=22301956

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002348693A Expired - Fee Related CA2348693C (en) 1998-10-19 1999-10-08 Natural formulation for the treatment and prevention of depression, containing st john's wort and derivatives of dihydro- and tetrahydrofolic acid

Country Status (4)

Country Link
EP (1) EP1121139A1 (en)
JP (2) JP2002527484A (en)
CA (1) CA2348693C (en)
WO (1) WO2000023089A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100814652B1 (en) * 2000-06-02 2008-03-18 메르크 파텐트 게엠베하 Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases
DE10315022A1 (en) * 2003-03-03 2004-09-23 Bioplanta Arzneimittel Gmbh Use of rutin or isorhamnetin, or plant parts or extracts containing them, to treat depression and related conditions, optionally incorporated into foods
UY29527A1 (en) * 2005-05-13 2006-12-29 Schering Ag PHARMACCUTIC COMPOSITION CONTAINING GESTRGENS AND / OR ESTRNGENS AND 5-METHYL - (6S) - TETRHYDROPHOLATE.
JP6333136B2 (en) * 2014-09-10 2018-05-30 サントリーホールディングス株式会社 Beverages containing St. John's wort extract
CN105687169B (en) * 2016-03-18 2018-06-12 西北工业大学 Application of the hypericin as cystathionine beta-synthase inhibitor
WO2022040740A1 (en) * 2020-08-25 2022-03-03 State of Mind Australasia Pty Ltd Method of treating depression and/or anxiety, and/or symptoms associated therewith

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229517B (en) * 1989-01-31 1991-09-03 Bioresearch Spa USE OF 5-METHYLTETRAHYDROPHOLIC ACID, OF 5 FORMYLTHETRAHYDROPHOLIC ACID, AND OF THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE SUITABLE FOR BEING EMPLOYED IN THE TREATMENT OF DISORDERS IN THE TREATMENT OF DISORDERS.
FR2643081B1 (en) * 1989-02-14 1991-06-07 Panmedica Sa MAGNESIUM FOLATES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS
US5820867A (en) * 1997-04-24 1998-10-13 Bewicke; Calverly M. General anti-depressant composition for dietary supplement
US6096317A (en) * 1998-01-13 2000-08-01 Rexall Sundown St. John's Wort and methyl donor composition and uses thereof
WO1999037155A1 (en) * 1998-01-27 1999-07-29 Nutramax Laboratories, Inc. Combinations of tyrosine, methylating agents, phospholipids, fatty acids, and st. john's wort for the treatment of mental disturbances

Also Published As

Publication number Publication date
CA2348693C (en) 2008-07-15
JP2011132250A (en) 2011-07-07
EP1121139A1 (en) 2001-08-08
JP2002527484A (en) 2002-08-27
WO2000023089A1 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
CA2233277A1 (en) Stable extract of hypericum perforatum l., processes for its preparation and pharmaceutical compositions
CA2411754A1 (en) 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
WO2002092028A3 (en) Oral care compositions
HUP0000589A2 (en) Aqueous formulations of peptides
AU3697197A (en) Use,in a composition, of an extract of at least one labiate
CA2370565A1 (en) Dermally applicable vitamin d-containing pharmaceutical compositions
IL114641A (en) Pharmaceutical compositions containing dispersible fluoxetine
HUT74980A (en) [dioxa-diaza/or oxa-triaza/-heptadienyl-phenyl]-acrylic and -glyoxilic acid derivatives, intermediates,preparation and use thereof, and fungicide, insecticide and acaricide compositions containing these compounds as active ingredients
HUP9802822A3 (en) Halobenzimidazol derivatives, intermediates, preparation thereof and microbocide compositions containing these compounds as active ingredients
EP1166792A3 (en) Extracts, compounds & pharmaceutical compositions having anti-diabetic activity and their use
CA2452326A1 (en) Topical leave-on compositions containing selected pantothenic acid derivatives
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
CA2361402A1 (en) Bis-sulfonamides
CA2271162A1 (en) Stearidonic acid compositions and uses thereof
CA2265993A1 (en) Novel antimicrobial cosmetic compositions
CA2343130A1 (en) Cosmetic composition
CA2176223A1 (en) Fenbendazole formulations
HUP9801881A3 (en) Hydroximic acid derivatives, preparation and use thereof, pesticide and fungicide compositions containing these compounds as active ingredients
CA2348693A1 (en) Natural formulation for the treatment and prevention of depression, containing st john's wort and derivatives of dihydro- and tetrahydrofolic acid
CA2359491A1 (en) Mixture of plant treatment compositions with waxes, their preparation, and their use
CA2272880A1 (en) Composition and method for reducing stinging in skin
HUP0102007A2 (en) Semi-solid aqueous pharmaceutical preparations for oral applications of toltrazuril sulphone
HUP9801651A3 (en) Hydroximic acid derivatives, intermediates, preparation and use thereof, pesticide compositions containing these compounds as active ingredients
HUP9700983A3 (en) 1,4-diaryl-2-fluoro-2-butene derivatives, intermediates, preparation and use thereof, insecticide and acaricide compositions containing these compounds as active ingredients
HUP9901137A3 (en) N-sulphonyl and n-sulphinyl amino acid derivatives, preparation thereof, microbicide compositions containing these compounds as active ingredients and use thereof

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed